Compare UK prices. 40+ products · 22 retailers scored
PeptideClear UK

Private blood test clinic

Rainbow Labs

London-based private blood test clinic with same-day results. Relevant to PeptideClear readers for GLP-1 bloods, hormone monitoring, and pre-prescription baseline testing.

Headline price

From GBP 39 per panel (full pricing on clinic site)

Regulated as

CQC-registered (verify before promoting)

Delivery area

London walk-in plus postal kit (verify scope)

Best for

Best for London-based readers needing same-day private blood tests

Weak on

London-clinic-only walk-in (postal kits may be available, verify). UK-wide reach via postal kits if offered.

What stands out

Our verdict

Rainbow Labs approved as a PeptideClear affiliate partner via Awin 21 May 2026. New category for PC: diagnostic partner for GLP-1 monitoring and pre-prescription baseline testing.

Last reviewed 2026-05-21. PeptideClear earns a referral fee when readers click through and convert. Editorial criteria are documented in our methodology.

Ready to start?

Visit Rainbow Labs →

Affiliate link. No price difference for you.

Reviewed by Oliver Mackman, editorial director · last reviewed 2026-06-18T12:00:00.000Z
Trust, Legal and Governance

PeptideClear is a trading name of Best Business Loans Ltd, registered in England and Wales (company number 16833937). All services, operations and publications under the PeptideClear brand are delivered by Best Business Loans Ltd.

Legal and Registration

Registered in England and Wales. Company number 16833937. D‑U‑N‑S 234324824. ICO registered, reference ZC151816 (certificate, verify). Registered supplier on the UK Government's Find a Tender Service (FTS). Details publicly available via Companies House and OpenCorporates.

Standards and Governance

Operates under UK data protection and consumer standards. Aligns with UK GDPR, ISO 27001 and ISO 9001 principles. Working towards Cyber Essentials certification.

Domain Continuity

Primary domain peptideclear.co.uk. Business ownership, entity and services remain unchanged. Reviewed quarterly.